Arden Trust’s Boston Scientific BSX Stock Holding History

Arden Trust’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-107,205	Closed	-$2.5M	–	346
2016 Q2	$2.5M	Sell	107,205 -2,631	-2%	-$56.9K	0.19%	122
2016 Q1	$2.07M	Buy	109,836 +99,108	+924%	+$1.74M	0.17%	141
2015 Q4	$198K	Sell	10,728 -1,075	-9%	-$19.3K	0.02%	594
2015 Q3	$194K	Buy	+11,803	New	+$202K	0.02%	653

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Arden Trust's BSX Position: Q3 2016 in Review

Arden Trust sold out of Boston Scientific (BSX) in Q3 2016, closing a stake of 107,205 shares — an estimated $2.5M sold.

Arden Trust first reported a position in BSX in Q3 2015 and held it in 4 quarters. The position peaked at $2.5M in Q2 2016. 568 funds tracked by Wall St. Rank hold BSX as of Q3 2016.

Arden Trust reported no remaining Boston Scientific position as of Q3 2016 after selling out during the quarter.
Arden Trust sold 107,205 Boston Scientific shares in Q3 2016, an estimated $2.5M.
Arden Trust first reported a position in Boston Scientific in Q3 2015 and held it in 4 quarters.
Arden Trust's Boston Scientific position peaked at $2.5M in Q2 2016.
568 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2016.

Based on Arden Trust's 13F filing for Q3 2016, filed 14 Oct 2016.